may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..

the us is rapidly running out of landfill space.

.

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..

. april 2015  (20).

.

her twins' cases were published, along with that of a third baby boy, in april in the